These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32043321)

  • 1. A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital.
    Zaitoon H; Bamberger E; Yaniv L; Mendelson B; Srugo I; Chistyakov I
    Isr Med Assoc J; 2020 Feb; 22(2):71-74. PubMed ID: 32043321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult Bacteremia: Should We Look for the Needle in the Haystack?
    Baram N; Megged O; Weiser G
    Isr Med Assoc J; 2016 Nov; 18(11):649-651. PubMed ID: 28466611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
    Sard B; Bailey MC; Vinci R
    Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).
    Ribitzky-Eisner H; Minuhin Y; Greenberg D; Greenberg N; Chodick G; Craiu M; Leibovitz E
    Pediatr Neonatol; 2016 Oct; 57(5):378-384. PubMed ID: 26738763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization.
    Leibovitz E; David N; Ribitzky-Eisner H; Abo Madegam M; Abuabed S; Chodick G; Maimon M; Fruchtman Y
    Int J Environ Res Public Health; 2016 Jul; 13(7):. PubMed ID: 27447651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.
    Lepoutre A; Varon E; Georges S; Gutmann L; Lévy-Bruhl D
    Euro Surveill; 2008 Aug; 13(35):. PubMed ID: 18761883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines.
    Greenhow TL; Hung YY; Herz A
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28283611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
    Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
    Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.
    Hernández-Bou S; Gómez B; Mintegi S; García-García JJ;
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1449-1455. PubMed ID: 29736610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced.
    Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G
    Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.